IFI-P · Dehydromatricarin Series

Specimen SS-F-TRP-885 // PUNGENT · IFI-P

Dehydromatricarin Series I-PR-A

Sinapis alba

White Mustard

Tier IDehydromatricarin Series

Target Trait

1.3×

fold-change

Dehydromatricarin sesquiterpene TRPA1 agonist fold-change

Technical Specifications

SKU

SS-F-TRP-885

Genomic Edits

3

GC Content

48.5%

Construct Length

2,416 bp

Promoter System

Ubiquitin / T7

Expression System

Protoplast PEG-fusion

Host Strain

PEG-mediated

Receptor Target

TRPA1

IFI Score

130

Pathway Edits

  • Germacrene-D synthase (GDS) overexpression for C15-germacrene-D sesquiterpene scaffold biosynthesis in Sinapis alba
  • FPPS upregulation for FPP sesquiterpene precursor pool expansion in mustard metabolic background
  • CYP450 sesquiterpene lactone ring-forming cyclase for germacrene-D guaianolide lactone ring closure

Key Interventions

GDS/CYP450 sesquiterpene lactone cascade establishes dehydromatricarin guaianolide biosynthesis from FPP in Sinapis albaAlpha-methylene-gamma-lactone pharmacophore completion enables TRPA1 Michael addition at Cys621 for reactive sesquiterpene TRPA1 agonismDehydromatricarin TRPA1 agonism confirmed by IFI-P calcium-flux assay; bitter-pungent Asteraceae sesquiterpene sensory profile validated in panelPEG-mediated transient expression protocol validated for rapid phenotypic pathway screening

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
—
IFI-K
—
IFI-C
—
IFI-P
130
IFI-A
—
IFI-F
—

Use Case

Tier I dehydromatricarin-enriched platform for Asteraceae sesquiterpene TRPA1 agonist ingredient production, bitter-pungent flavor applications in herbal extracts, and research-grade guaianolide lactone supply for TRPA1 electrophile pharmacology. Suitable for flavor researchers exploring sesquiterpene lactone sensory axes and specialty bitter-pungent flavor ingredient developers for digestif, medicinal herb, and functional wellness product applications.

License

$299 · Tier I License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Pungent · IFI-PAll Modalities